Invesco Advantage MIT II (VKI) — Cash Flow Reinvestment Rate
Invesco Advantage MIT II (VKI) has a Cash Flow Reinvestment Rate of 0.00x as of August 2025, reinvesting $4.00 (capex $4.00 ) from operating cash flow of $8.44 Million. See cash generation quality of Invesco Advantage MIT II to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Invesco Advantage MIT II Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Invesco Advantage MIT II across 17 annual periods. For the full cash flow conversion analysis, see Invesco Advantage MIT II (VKI) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Invesco Advantage MIT II (2007–2025)
Year-by-year capital reinvestment analysis for Invesco Advantage MIT II. See Invesco Advantage MIT II financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $0.00 | $51.42 Million | $0.00 | ▼ -100.0% |
| 2024 | 0.00x | $4.00 | $15.87 Million | $4.00 | — |
| 2023 | 0.00x | $0.00 | $87.71 Million | $0.00 | — |
| 2022 | 0.00x | $0.00 | $33.62 Million | $0.00 | — |
| 2021 | 0.00x | $0.00 | $43.84 Million | $0.00 | — |
| 2020 | 0.00x | $0.00 | $14.55 Million | $0.00 | — |
| 2019 | 0.00x | $0.00 | $47.57 Million | $0.00 | — |
| 2018 | 0.00x | $0.00 | $54.40 Million | $0.00 | — |
| 2017 | 0.00x | $0.00 | $20.50 Million | $0.00 | — |
| 2016 | 0.00x | $0.00 | $31.45 Million | $0.00 | — |
| 2015 | 0.00x | $0.00 | $23.20 Million | $0.00 | — |
| 2014 | 0.00x | $0.00 | $41.24 Million | $0.00 | — |
| 2013 | 0.00x | $0.00 | $44.05 Million | $0.00 | — |
| 2012 | 0.00x | $0.00 | $29.89 Million | $0.00 | — |
| 2011 | 0.00x | $0.00 | $77.15 Million | $0.00 | ▼ -100.0% |
| 2009 | 5.21x | $137.81 Million | $26.43 Million | $0.00 | ▲ +39.8% |
| 2007 | 3.73x | $137.81 Million | $36.95 Million | $0.00 | — |